Has Jeff Hsing, MD received payments from drug or device companies?

Yes. Drug and device makers reported $89,292 in general payments to Jeff Hsing, MD across 193 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeff Hsing, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeff Hsing, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeff Hsing, MD

Clinical Cardiac Electrophysiology · Corvallis, ORNPI 1427128644

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $74,200 of the $89,292 with a category attached, or 83.1%. Medtronic accounts for 88.9% of it on its own, with 11 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$89,292in general payments, 2019–2025

Across 193 payments — averaging $462.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$79K
Abbott$9K
Medline Industries LP$458
Boston Scientific$385
Abiomed$144
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$96
plus $168 from 6 others

$40,107in research payments, 2019–2025

Across 17 payments — averaging $2359.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$36K
Boehringer Ingelheim$5K

What the payments were for

Speaking & faculty fees$74,20083%
Travel & lodging$7,7549%
Food & beverage$7,3388%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	83	$79,344
Abbott	83	$8,698
Medline Industries LP	5	$458
Boston Scientific	6	$385
Abiomed	1	$144
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$96
Teleflex LLC	3	$59
AstraZeneca	2	$33
Shockwave Medical, Inc	1	$32
Cardiva Medical, Inc.	1	$18
Philips North America LLC	1	$15
Amgen	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENSITE$3,972
ENSITE PRECISION$1,646
SelectSecure$482
VANTAGEVIEW$379
ATTAIN COMMAND + SUREVALVE$338
TactiCath Quartz CFA Catheter$270
NA$239
ADVISOR$167
EnSite Precision Cardiac Mapping System$154
AURORA EV-ICD MRI SURESCAN$149
Advisor Catheter$149
ASSURITY$136
PulseSelect$124
DYNAGEN$122
Confirm Rx$114
WATCHMAN Access System$109

How this compares

$89,292 in reported general payments places this provider in the 95th percentile of 37 clinical cardiac electrophysiology providers in Oregon.

See all clinical cardiac electrophysiology providers in Oregon →

Medicare billing

Part B allowed, 2024

$217,140

Medicare patients

887

Services billed

2,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	240	$275,635
XareltoRivaroxaban	50	$45,047
EntrestoSacubitril/Valsartan	16	$25,281
Flecainide Acetate	141	$5,757
Metoprolol Succinate	128	$3,351
Amiodarone Hcl	111	$2,671
Mexiletine Hcl	20	$1,271
Colchicine	50	$1,214
Diltiazem 24hr Er (Cd)Diltiazem Hcl	23	$1,130
SotalolSotalol Hcl	23	$620
Omeprazole	41	$529
Lactated RingersRinger's Solution,lactated	11	$524
Carvedilol	31	$387
Losartan Potassium	12	$276
Rosuvastatin Calcium	11	$211

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Corvallis

Ross DowneyCorvallis$1K
Robert FlorekHood River$376K
Nathaniel McConkeyPortland$56K
Sandeep SahaSalem$52K
Jonathan LowyBend$46K
Edward ChengGresham$39K
Michael Charles TanPortland$38K
Ashit PatelSalem$36K
Saket SanghaiPortland$36K
Hiro KawataSpringfield$23K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →